Hepatocellular Carcinoma Clinical Trials in Baltimore, Maryland

3 studies are recruiting for hepatocellular carcinoma in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

    This research is designed to determine if experimental treatment with AZD9793, a T cell-engaging antibody that targets GPC3, is safe, tolerable and has anti-cancer activity in patients with advanced or metastatic solid tumours which are GPC3+.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Site, Baltimore, Maryland
    Locations
    21 in total
    Run by
    AstraZeneca

    See if you can join NCT06795022 on ClinicalTrials.gov

  2. A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

    The primary objectives of Cohort A Phase 1b and exploratory expansion are to evaluate the safety and tolerability of TTI-101 orally administered as a single agent to participants with locally advanced or metastatic, and unresectable Hepatocellular Carcinoma (HCC) and to determine the maximum tolera…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
    Locations
    21 in total
    Run by
    Tvardi Therapeutics, Incorporated

    See if you can join NCT05440708 on ClinicalTrials.gov

  3. Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

    The purpose of this study is to assess the efficacy and safety of RP2 in combination with atezolizumab plus bevacizumab (Cohorts 1a and 1b) and RP2 monotherapy (Cohort 2) in the as second line treatment in patients with locally advanced unresectable, recurrent, and/or metastatic HCC and in combinat…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Maryland Medical Center, Baltimore, Maryland
    Locations
    12 in total
    Run by
    Replimune, Inc.

    See if you can join NCT05733598 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.